Ovarian Adenocarcinoma

Also known as: Adenocarcinoma Ovary / Ovary Adenocarcinoma / Adenocarcinoma of the Ovaries / Adenocarcinoma of the Ovary / Ovarian epithelial cancer / Ovarian epithelial cancer NOS

DrugDrug NameDrug Description
DB00531CyclophosphamideA nitrogen mustard used to treat lymphomas, myelomas, leukemia, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma.
DB04572ThiotepaAn alkylating agent used to prevent graft rejection in stem cell transplantation and to treat a variety of malignancies including certain types of adenocarcinoma and superficial bladder carcinomas.
DrugDrug NamePhaseStatusCount
DB00112Bevacizumab1Completed1
DB17323CRS-2071Terminated1
DB00515Cisplatin1Completed1
DB00531Cyclophosphamide1Terminated1
DB17324Listeria monocytogenes1Terminated1
DB18452AVB-0011 / 2Active Not Recruiting1
DB00531Cyclophosphamide1 / 2Active Not Recruiting1
DB17436DNP-Modified autologous tumor vaccine1 / 2Unknown Status1
DB01073Fludarabine1 / 2Active Not Recruiting1
DB00112Bevacizumab2Terminated1
DB14905Emactuzumab2Terminated1
DB16419Ieramilimab2Completed1
DB06186Ipilimumab2Active Not Recruiting1
DB09035Nivolumab2Active Not Recruiting1
DB01229Paclitaxel2Terminated1
DB14892Spartalizumab2Completed1